| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $5.99 ▲ +1.77% | Yesterday | $5.85 ▼ -0.74% | Tomorrow's Xeris Biopharma Holdings Inc. Common Stock (XERS) setup is anchored to $5.89 and targets $5.99 (+1.77%). The near-term read is upside; watch $6.07 / $5.71 because daily realized volatility is about 8.00%. |
Tomorrow's Xeris Biopharma Holdings Inc. Common Stock (XERS) setup is anchored to $5.89 and targets $5.99 (+1.77%). The near-term read is upside; watch $6.07 / $5.71 because daily realized volatility is about 8.00%. | ||||
| Week | $6.21 ▲ +5.50% | Last Week | $5.75 ▼ -2.31% | The 7-day Xeris Biopharma Holdings Inc. Common Stock model moves from $5.75 to $6.21 (+5.50%). It gives upside momentum context for this stock, so breaks around $6.07 / $5.71 matter more than a single tick. |
The 7-day Xeris Biopharma Holdings Inc. Common Stock model moves from $5.75 to $6.21 (+5.50%). It gives upside momentum context for this stock, so breaks around $6.07 / $5.71 matter more than a single tick. | ||||
| Month | $6.58 ▲ +11.71% | Last Month | $5.60 ▼ -4.92% | The 1-month Xeris Biopharma Holdings Inc. Common Stock target is $6.58 (+11.71%), compared with the live reference near $5.89. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Xeris Biopharma Holdings Inc. Common Stock target is $6.58 (+11.71%), compared with the live reference near $5.89. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $7.13 ▲ +21.03% | Last Year | $5.37 ▼ -8.83% | The 1-year Xeris Biopharma Holdings Inc. Common Stock scenario points to $7.13 (+21.03%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Xeris Biopharma Holdings Inc. Common Stock scenario points to $7.13 (+21.03%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $8.41 ▲ +42.86% | 5 Years Ago | $4.83 ▼ -18.00% | The 5-year Xeris Biopharma Holdings Inc. Common Stock view is $8.41 (+42.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Xeris Biopharma Holdings Inc. Common Stock view is $8.41 (+42.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $5.89 | Mid |
| Daily Change | -5.76% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 70% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $5.89 | Daily Change | -5.76% |
| Market Cap | $1.02B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.